First, we showed that PF543 administered following bleomycin exposure reduces lung expression of markers indicative of ongoing pulmonary fibrosis by activated fibroblasts such as fibronectin, Col1A2, and α-SMA (Figure 3) in a manner that parallels our histologic findings (Figure 2). The gene discussed is COL1A2; the disease is pulmonary fibrosis.